Dicerna pharmaceuticals tender offer
WebJan 2, 2024 · LEXINGTON, Mass.–(BUSINESS WIRE)–Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2024, has been completed.Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of … WebNov 18, 2024 · Novo Nordisk (NVO) has signed an agreement with Dicerna Pharmaceuticals (DRNA) under which it will acquire Dicerna for $38.25 per share in cash. ... Novo Nordisk expects to make a tender offer ...
Dicerna pharmaceuticals tender offer
Did you know?
WebDec 28, 2024 · Novo Nordisk has been advised by the depositary for the tender offer that almost 65 million shares of Dicerna’s common stock were validly tendered and not validly withdrawn in the tender offer as of the expiration fo the tender offer at 5 p.m. ET on Dec. 27, 2024, representing approximately 82.6% of the total number of shares of Dicerna’s ...
WebWe go right to the source. Genes play a primary role in thousands of diseases. At Dicerna, we use our proprietary GalXC™ platform to develop RNAi therapies that aim to target … WebNov 18, 2024 · Davis Polk is advising Novo Nordisk on its approximately $3.3 billion acquisition of Dicerna Pharmaceuticals, Inc. Under the terms of the acquisition agreement, Novo Nordisk will initiate a tender offer to acquire all outstanding shares of Dicerna. The closing of the tender offer will be subject...
WebThis Tender Offer Statement on Schedule TO (this “Schedule TO”) relates to the offer by NNUS New Research, Inc., a Delaware corporation (“Purchaser”), and Novo Nordisk … WebDec 27, 2024 · Novo Nordisk has filed a Tender Offer Statement on Schedule TO with the SEC containing an offer to purchase all of the outstanding shares of Dicerna common stock for $38.25 per share, and Dicerna ...
WebDec 8, 2024 · DRNA Dicerna Pharmaceuticals Inc Amended Tender Offer Statement by Third Party (sc To-t/a) ... Purchaser to purchase all of the outstanding shares of common …
WebDec 25, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, … dallas international school waterview campusWebNov 18, 2024 · Upon the successful completion of the tender offer, Novo Nordisk’s acquisition subsidiary will be merged into Dicerna, and any remaining shares of common … birchmeyer auction serviceWebAt Dicerna, we use RNA interference, or RNAi, to create medicines that silence or turn off the genes that cause or contribute to disease. Using our GalXC™ and GalXC-Plus™ technologies , we aim to develop safe, … dallas international school employmentWebDec 27, 2024 · -- Novo Nordisk on Thursday reached a definitive agreement to acquire Dicerna Pharmaceuticals with a cash tender offer of $38.25 per share, for a total value of around $3.3 billion. The closing of... April 11, 2024 birchmeyer automotive las cruces nmWebDec 28, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), … birchmeyer automotiveWebNov 17, 2024 · DICERNA PHARMACEUTICALS, INC., a Delaware corporation . Dated as of November 17, 2024 . Table of Contents . Section 1 . THE OFFER . 1.1 : The Offer : 2 : 1.2 ... Purchaser shall commence a tender offer (as it may be amended from time to time as permitted under this Agreement, ... birch mews autos eastbourneWebFollowing the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstanding shares of common stock of Dicerna at a price of USD 38.25 per share in cash, without interest and less any applicable tax withholding. ... Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research ... dallasinternationalschool.org